治疗耐治疗强迫症的胺:双盲主动控制交叉研究
Ben Beaglehole1, Paul Glue2, Shona Neehoff2
1Department of Psychological Medicine, University of Otago, Christchurch, New Zealand.
Journal of psychopharmacology (Oxford, England)
|November 28, 2024
概括
肌肉内胺显示出治疗严重强迫症 (OCD) 的前景. 这项研究发现,相比芬太尼,胺显著降低了强迫症症状,提供了潜在的新治疗途径.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床神经科学 临床神经科学
背景情况:
- 强迫症 (OCD) 在耐治疗病例中提出了重大挑战.
- 探索新型治疗剂对于改善患者的治疗结果至关重要.
研究的目的:
- 为了比较肌肉内注射 (IM) 胺与 IM 芬太尼在治疗不耐药的强迫症患者中的疗效和耐受性.
- 在这个患者群体中评估胺的剂量反应关系.
主要方法:
- 一项随机,双盲,精神活性受控的研究,涉及单剂量的胺 (0.5毫克/公斤或1.0毫克/公斤) 或芬太尼 (50微克).
- 参与者接受了Ondansetron用于恶心预防.
- 耶鲁-布朗强迫性强迫性尺度 (Y-BOCS) 是主要的疗效测量标准,临床医师管理的分离状态尺度 (CADSS) 评估了耐受性.
主要成果:
- 与芬太尼相比,Y-BOCS得分的降低显著更大,与胺相比,与剂量相关 (p=0.031).
- 症状改善在服用后1-2小时达到顶峰,持续至168小时.
- 胺与短暂的分离和心血管影响有关.
结论:
- 初步证据支持IM胺在强迫症门诊治疗中的有效性和耐受性.
- 需要进一步的研究来确定最佳剂量和长期有效性.
- 这些发现为一个治疗选择有限的人群提供了希望.
相关概念视频
Psychosis: Goals of Pharmacotherapy
104
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
104
Crossover Experiments
2.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.7K
Obsessive-Compulsive Disorder
54
Obsessive-compulsive disorder (OCD) is a mental health condition characterized by recurrent obsessions, compulsions, or both, which consume significant time and interfere with daily functioning. Obsessions involve persistent, intrusive, and unwanted thoughts, images, or urges that evoke anxiety. Common examples include irrational fears of contamination or harm. Compulsions are repetitive behaviors or mental acts performed to reduce the anxiety caused by obsessions. For instance, individuals...
54
Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25


